Tracey Genus

Most-cited papers

1. Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis

   M. M. OudeLuttikhuis, J. Powell, S. A. Rees, Tracey Genus +4 more

   2001British Journal of Cancer75 citations Open access

   Semantic Scholar

   Save

2. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013–2015

   Tracey Genus, C. Bouvier, K. Wong, R. Srirajaskanthan +12 more

   2019British Journal of Cancer73 citations Open access

   Semantic Scholar

   Save

3. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.

   Shahid A. Khan, Tracey Genus, H. Morement, Andrew Murphy +2 more

   2019Journal of Hepatology50 citations Open access

   Semantic Scholar

   Save

4. How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001–2012

   D. Ward, A. Slade, Tracey Genus, O. Martino +1 more

   2014BMJ Open20 citations Open access

   Semantic Scholar

   Save

5. Incidence and prevalence of neuroendocrine tumours in England

   Tracey Genus, C. Bouvier, Wong Kwok, R. Srirajaskanthan +10 more

   20178 citations

   Semantic Scholar

   Save

6. Multilocus loss of heterozygosity allelotypes identify a genetic pathway associated with progression from low to high stage disease in neuroblastoma.

   S. Chughtai, Tracey Genus, Pramila Ramani, S. Dyer +4 more

   2006European Journal of Cancer6 citations

   Semantic Scholar

   Save

7. Incidence and prevalence of neuroendocrine neoplasms reported in England from 2015 to 2017

   B. White, C. Bouvier, Tracey Genus, B. Rous +3 more

   20193 citations

   Semantic Scholar

   Save

8. (late submission poster) Incidence and mortality rates of cholangiocarcinoma in England.

   Tracey Genus, D. Tataru, H. Morement, M. Toledano +1 more

   2019Annals of Oncology2 citations Open access

   Semantic Scholar

   Save

9. Incidence and Prevalence of Neuroendocrine Tumors in England

   Tracey Genus, C. Bouvier, K. Wong, R. Srirajaskanthan +8 more

   20182 citations

   Semantic Scholar

   Save

10. O42 Incidence of neuroendocrine neoplasms in England 2015–2017

    B. White, C. Bouvier, Tracey Genus, K. Chandrakumaran +5 more

    20211 citations Open access

    Semantic Scholar

    Save

11. Metachronous Primary Cancers in Neuroendocrine Tumor Patients

    Tracey Genus, C. Bouvier, Wong Kwok, Rajaventhan Srirajaskanthan +10 more

    20171 citations

    Semantic Scholar

    Save

12. New and emerging health technologies for corneal disorders

    Tracey Genus, S. Simpson, D. Ward

    20161 citations

    Semantic Scholar

    Save

13. Metachronous neuroendocrine neoplasms in England 2013-2015

    B. White, Tracey Genus, C. Bouvier, J. Ramage +1 more

    20200 citations

    Semantic Scholar

    Save

14. Cholangiocarcinoma in England - a national study examining changes in incidence, diagnostic routes and overall survival

    Tracey Genus, D. Tataru, H. Morement, M. Toledano +1 more

    2020Journal of Hepatology0 citations Open access

    Semantic Scholar

    Save

15. 1-Year survival rates for neuroendocrine tumour patients in England

    Tracey Genus, C. Bouvier, Wong Kwok, R. Srirajaskanthan +10 more

    20170 citations

    Semantic Scholar

    Save